Related Experiment Video
Updated: Jul 16, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
[Variable progression of autosomal dominant polycystic kidney disease: genetic and molecular counterparts]
1Service de néphrologie, cliniques universitaires Saint-Luc, faculté de médecine, université catholique de Louvain, 10, avenue Hippocrate, 1200 Bruxelles, Belgique. Devuyst@nefr.ucl.ac.be
Abstract:
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by a variable renal disease progression, which is observed both between (inter-familial variability) and within (intra-familial variability) affected families. Inter-familial variability is primarily due to genetic heterogeneity (PKD1 vs. PKD2), although an influence of the nature/type of mutation may also interfere (at least for PKD1). The major factor influencing intra-familial variability is probably the occurrence of a somatic mutation in the intact allele within epithelial tubular cells ("second hit"). Studies of variability in siblings and twins, as well as in animal models, suggest that modifier genes also influence renal disease progression in ADPKD, in addition to environmental or toxic factors. These modifier loci could affect cystogenesis and/or cyst progression, but also more general factors such as blood pressure regulation or endothelial function. Substantiating the role of modifier genes will require large familial studies but will probably offer new perspectives to slow renal disease progression in ADPKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Pedigree Analysis
Nephrons
Diabetic Nephropathy

